Schuetz Thomas J. (CIK 0001591464)

Latest company ownership

Shares held
6,436,800
Last filed at
Nov 18, 2025
Confidence Score
46.4
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 16, 2025 Nov 18, 2025 Compass Therapeutics, Inc. CEO Sell 45.0 -44,025 -0.68% ✗ $212.6K
May 27, 2025 May 27, 2025 Compass Therapeutics, Inc. CEO Buy 56.3 +10,000 0.15% ✗ $21.1K
Feb 8, 2025 Feb 11, 2025 Compass Therapeutics, Inc. CEO Sell 45.0 -41,687 -0.64% ✗ $145.9K
Jan 9, 2025 Jan 13, 2025 Compass Therapeutics, Inc. CEO Sell 45.0 -58,054 -0.88% ✗ $108K
Feb 8, 2024 Feb 9, 2024 Compass Therapeutics, Inc. President Sell 45.0 -44,782 -0.68% ✗ $64.9K
Nov 17, 2023 Nov 21, 2023 Compass Therapeutics, Inc. CEO Sell 45.0 -44,025 -0.73% ✗ $66K
Mar 10, 2023 Mar 10, 2023 Compass Therapeutics, Inc. CEO Buy 56.3 +10,000 0.17% ✗ $33.7K
Feb 27, 2023 Feb 27, 2023 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.33% ✗ $79.6K
Feb 15, 2023 Feb 15, 2023 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.33% ✗ $77.2K
Jan 31, 2023 Jan 31, 2023 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.37% ✗ $81K
Jan 24, 2023 Jan 24, 2023 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.37% ✗ $83.8K
Sep 28, 2022 Sep 28, 2022 Compass Therapeutics, Inc. CEO Buy 56.3 +10,000 0.18% ✗ $23.2K
Sep 26, 2022 Sep 27, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +15,000 0.28% ✗ $34.1K
Sep 7, 2022 Sep 8, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +15,000 0.28% ✗ $45.5K
Sep 1, 2022 Sep 1, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +15,000 0.28% ✗ $42.5K
Aug 17, 2022 Aug 17, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +15,000 0.28% ✗ $45.8K
Aug 10, 2022 Aug 10, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +15,000 0.28% ✗ $39.6K
Aug 1, 2022 Aug 2, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +15,000 0.28% ✗ $38.7K
Jun 21, 2022 Jun 21, 2022 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.38% ✗ $56K
Jun 16, 2022 Jun 17, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +20,000 0.38% ✗ $46.8K
Jun 13, 2022 Jun 13, 2022 Compass Therapeutics, Inc. CEO Buy 72.5 +30,000 0.57% ✗ $68.7K
Jun 6, 2022 Jun 7, 2022 Compass Therapeutics, Inc. CEO Buy 72.5 +30,000 0.57% ✗ $84.9K
Jun 1, 2022 Jun 1, 2022 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.38% ✗ $60.6K
May 26, 2022 May 26, 2022 Compass Therapeutics, Inc. CEO Buy 65.0 +20,000 0.39% ✗ $60.8K
May 23, 2022 May 24, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +18,355 0.35% ✗ $49.9K
May 17, 2022 May 17, 2022 Compass Therapeutics, Inc. CEO Buy 61.3 +20,215 0.39% ✗ $49.9K
May 10, 2022 May 10, 2022 Compass Therapeutics, Inc. CEO Buy 72.5 +27,836 0.54% ✗ $50.1K
Jun 19, 2020 Jun 23, 2020 Compass Therapeutics, Inc. CEO Buy 85.0 +97,431 2.20% ✗ $487.2K